Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML

• Kalpana Gupta,

  Affiliation Department of Pathology, Case Western Reserve School of Medicine, Cleveland, Ohio, United States of America

  ⨯
• Amitabha Chakrabarti,

  Affiliation Invenio Therapeutics, Cleveland, Ohio, United States of America

  ⨯
• Sonia Rana,

  Affiliation Invenio Therapeutics, Cleveland, Ohio, United States of America

  ⨯
• Ritu Ramdeo,

  Affiliation Department of Pathology, Case Western Reserve School of Medicine, Cleveland, Ohio, United States of America

  ⨯
• Bryan L. Roth,

  Affiliation Departments of Pharmacology and Medicinal Chemistry, University of North Carolina Chapel Hill Medical School, Chapel Hill, North Carolina, United States of America

  ⨯
• Munna L. Agarwal,

  Affiliation Department of Genetics, Case Western Reserve School of Medicine, Cleveland, Ohio, United States of America

  ⨯
• William Tse,

  Affiliation Department of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Mukesh K. Agarwal ,

  * E-mail: agarwamukesh@yahoo.com (MKA); dnw@case.edu (DNW)

  Affiliation Invenio Therapeutics, Cleveland, Ohio, United States of America

  ⨯
• David N. Wald

  * E-mail: agarwamukesh@yahoo.com (MKA); dnw@case.edu (DNW)

  Affiliations Department of Pathology, Case Western Reserve School of Medicine, Cleveland, Ohio, United States of America, Invenio Therapeutics, Cleveland, Ohio, United States of America, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America

  ⨯